When considering the future of drug delivery, the interplay between healthcare and the environment cannot be ignored. From global disasters that disrupt supply chains to increasing pressures to reduce emissions, there is a clear need to increase resilience in the production and supply of life-saving drugs and devices.
In our latest article in OnDrugDelivery, we explore the complexities of this challenge and the key steps we’re already taking to tackle it as the specialist inhalation CDMO, from partnering with local companies to leading the transition to low GWP propellants.
Read the full article to learn more.
